Research

Making Progress

A drug with potential to treat COVID-19 symptoms is moving to human clinical trials.

A drug with potential to treat COVID-19 symptoms is moving to human clinical trials.

Researchers at Carolina’s Gillings School of Global Public Health have been playing a key role in the development and testing of drugs to treat COVID-19 patients.

Currently, no antiviral drugs have been approved to treat any coronavirus that causes human disease.

However, based on recent discoveries,scientists are hopeful that a new drug, called EIDD-2801, could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials.

“This new drug not only has high potential for treating COVID-19 patients, but also appears effective for the treatment of other serious coronavirus infections,” saidWilliam R. Kenan Jr. Distinguished Professor of epidemiology Ralph Baric.

Read the complete Carolina Story…Opens in new window

Carolina on the Frontlines

UNC-Chapel Hill is on the frontlines of the COVID-19 pandemic. View the ways you can immediately support Carolina researchers, caregivers and students who drive change, accelerate impact and provide a future for us all.

Support Carolina on the Frontlines

UNC Gillings School of Public Health Funding Priorities

Readers Also Viewed...

Community

Emergency Preparedness, Ethics and Equity Speaker Series

Fostering inclusive excellence during turbulent times

Ralph Baric
Research

Remdesivir proves effective

“Game-Changer” treatment for patients with COVID-19

Health

Monitoring asymptomatic COVID-19 cases

Partnering with state and local agencies to assess COVID-19 prevalence

Ralph Baric
Research

In Search of the Most Effective COVID-19 Therapeutics

Ralph Baric and his team are testing hundreds of existing compounds against COVID-19 for researchers and labs across the world, in search of the most effective therapeutics.

Rachel Noble
Research

Testing Water Systems for COVID-19

UNC-Chapel Hill researcher Rachel Noble is studying the transmissibility of COVID-19 through water and the environment.

Innovation

Monitoring Disease through Social Media

Can social media help track the spread of disease?